RG

Robert Getts

Chief Technology Officer

Code BioTherapeutics


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Code BioTherapeutics
Industry
research
Employees
37.0
Seniority
C suite
Annual Revenue
100000.0
Total Funding
85000000.0
Latest Funding
Series A

Technologies

Route 53 Outlook Microsoft Office 365 Google Cloud Hosting Varnish Google Tag Manager Google Analytics Mobile Friendly Wix Viewpoint

Keywords

biotechnology research genetic medicine 3dna delivery platform non-viral delivery gene therapy targeted delivery rnai precision medicine bioavailability modular delivery duchenne muscular dystrophy (dmd) cell specific targeting re-dosable genetic medicines immunogenicity dose related toxicity off-target effects therapeutic potency synthetic dna genetic disorders rare diseases gene editing vector manufacturing therapeutic cargo biodistribution cell internalization safety profiles multivalent structure peptide targeting nanotechnology preclinical development patient-specific therapy biopharmaceutical research innovative drug delivery modular manufacturing gene constructs chronic dosing therapeutic efficacy drug development translational medicine collaboration in drug discovery clinical research disease modulation tissue specific promoter biosafety target identification molecular delivery systems next generation therapeutics advanced gene therapy solutions forbidden targets

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans